Patents by Inventor Andrew Hu

Andrew Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12141191
    Abstract: Aspects of the present disclosure involve a system comprising a computer-readable storage medium storing a program and method for displaying a profile from a content feed within a messaging system. The program and method provide for receiving by a messaging application, first user input corresponding to a request for a content feed, the content feed comprising a plurality of media content items; providing, in response to receiving the first user input, for display of the content feed; receiving, by the messaging application, second user input of a predefined gesture performed with respect to a first media content item of the plurality of media content items; determining, in response to receiving the second user input and based on the first media content item, to display a public profile associated with the first media content item; and providing, based on the determining, for display of the public profile.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: November 12, 2024
    Assignee: SNAP INC.
    Inventors: Newar Husam Al Majid, Alex Beltyukov, Nathan Kenneth Boyd, Jacob Catalano, Wenbin Chen, Matthew Lee Cook, Andrew Grosvenor Cooper, Zuoyou Gu, Yue Hu, Timothy Kautz, Edward Koai, Jong-Hwi Lee, Chinmay Lonkar, Lu Lu, Zachary Lupei, Charles Melbye, Celia Nicole Mourkogiannis, Chiung-Fu Shih, Brian Yee, Jiawen Zeng, Dongguang Zhao
  • Publication number: 20240368170
    Abstract: Cinnoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the cinnoline compounds.
    Type: Application
    Filed: July 10, 2024
    Publication date: November 7, 2024
    Applicant: Genentech, Inc.
    Inventors: Sushant Malhotra, Michael Siu, Weiru Wang, BinQing Wei, Aihe Zhou, Bryan K. Chan, Lewis J. Gazzard, Timothy Heffron, Michael Lainchbury, Andrew Madin, Eileen Mary Seward, Matthew W. Cartwright, Emanuela Gancia, David Favor, Kin Chiu Fong, Andrew Good, Yonghan Hu
  • Publication number: 20240370009
    Abstract: A method for using time-series data to predict remaining useful life of industrial equipment in cases where limited time-series training data is available is described. The method includes steps of monitoring the industrial equipment to sense historical time-series data associated with the industrial equipment using at least one sensor, storing the historical time-series data from the at least one sensor, accessing the historical time-series data and pre-processing the historical time-series data to extract higher-level features associated with the remaining useful life of the industrial equipment, and applying a jointly trained health predictor to the higher-level features using a computing device by executing a set of instructions from a non-transitory machine readable memory using a processor of the computing device to determine a prediction for the remaining useful life of the industrial equipment.
    Type: Application
    Filed: April 30, 2024
    Publication date: November 7, 2024
    Applicants: Iowa State University Research Foundation, Inc., Percev LLC
    Inventors: Venkat Pavan Nemani, Chao Hu, Carey E. Novak, Andrew T. Zimmerman
  • Publication number: 20240350908
    Abstract: Embodiments of the present disclosure may include a method for providing cross-platform multi-user compatibility in a cross-play cloud computing environment, the method including simulating at least one instance of an entertainment program. Embodiments may also include providing access to the at least one instance of the entertainment program asynchronously from two or more client devices via one of a plurality of independent entertainment platforms. In some embodiments, the two or more client devices may be able to engage in multi-user functionality within the at least one instance of the entertainment program via the one of a plurality of independent entertainment platforms. Embodiments may also include synchronizing the multi-user functionality within the at least one instance of the entertainment program.
    Type: Application
    Filed: August 30, 2022
    Publication date: October 24, 2024
    Applicant: TLM Partners, Inc.
    Inventors: Jacob HAWLEY, Mark HU, Murray VINCE, Jeremy PAVIER, Christopher BURNS, Hrafnkell Freyr HLOEDVERSSON, Andrew MEDVEDEV
  • Publication number: 20240294487
    Abstract: Disclosed are XBP-1/IRE-1 inhibitors having formula disclosed herein. Methods of making and using these inhibitors for the treatment of cancer, in particular B cell cancers, are also disclosed. Also disclosed is a genetic XBP-1-knockout cancer mouse model.
    Type: Application
    Filed: January 3, 2024
    Publication date: September 5, 2024
    Inventors: Juan R. Del Valle, Chih-Chi Andrew Hu
  • Patent number: 12072296
    Abstract: A portable visual inspection apparatus comprises a box including a lower box portion and an upper box portion. The upper box portion defines a first accommodation space and is connected to the lower box portion such that is capable of being opened and closed. A visual inspection device is installed in the first accommodation space and is adapted to be switched between an expanded configuration in which the visual inspection device is at least partially expanded for photographing an image of an article, and a folded configuration in which the visual inspection device is at least partially folded for storage in the first accommodation space. A support platform is arranged in the lower box portion and defines an inspection area below the visual inspection device in the expanded configuration. The portable visual inspection apparatus is switchable between a use configuration and a transportation configuration.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: August 27, 2024
    Assignees: Tyco Electronics (Shanghai) Co., Ltd., TE Connectivity Solutions GmbH
    Inventors: Lei (Alex) Zhou, Qing (Carrie) Zhou, Yun (Shanghai) Liu, Huabin Du, Mark Andrew Ondo, Sonny O Osunkwo, Lvhai (Samuel) Hu, Dandan (Emily) Zhang, Roberto Francisco-Yi Lu
  • Patent number: 12071608
    Abstract: An interface for coupling a dissolved oxygen sensor to a single-use bioreactor container is provided. A dissolved oxygen (DO) window membrane is operably coupled to the single-use container and configured to position a DO sensor at least partially within the single-use container. In some embodiments, a DO window body mounts the DO window membrane at a distal end thereof. The DO window body can include a slide lock for facilitating positioning of a DO sensor within the DO window body. Additionally, the DO window body may include at least one heat exchange fin.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: August 27, 2024
    Assignee: Rosemount Inc.
    Inventors: Andrew S. Dierker, Jinbo Hu, Tyrel L. Ruch, Rick J. Sumrall, Taufiq Ahmed, Ryan L. Bowlds, Michalle J. A. Adkins, Marc R. Mason, John W. Simon
  • Publication number: 20240281853
    Abstract: Techniques are described for a social networking system to provide a collaborative fundraising event that allow for multiple organizers of the event to publish, receive attribution, and edit fundraiser content. In some cases, the social networking system may be configured to distribute the fundraiser content based on metrics, support, and relationships between organizers and other users of the social networking system.
    Type: Application
    Filed: December 10, 2021
    Publication date: August 22, 2024
    Inventors: Francesco Fogu, Lauren Wong, Andrew Bower, Jizhi Hu, Cristina Foung, Levi Gemmell
  • Publication number: 20240245582
    Abstract: Systems and methods for distribution, storage, transport, administration and/or disposal of one or more therapeutic or diagnostic agents are disclosed. A storage device configured to connect to a delivery system for delivering the therapeutic or diagnostic agent has a housing with a chamber, a vessel having an access port positioned within the chamber. The door is movable relative to the housing between a closed position and an open position. In the closed position, the door covers an opening in the housing to enclose the chamber, and, in the open position, the door reveals the opening for accessing the access port of the vessel. The door is moveable between the closed position and the open position in response to actuation by an access mechanism of the delivery system.
    Type: Application
    Filed: February 8, 2024
    Publication date: July 25, 2024
    Inventors: John Volkar, Joana Oliveira Rego Brilhante, Anne Berit Eid, Ellia Hu, Hamsini Sundararaman, Ashley Cockerham, Winston Ge, Andrew Jones, Rich Miller, Joe Ting, Brian Yoo, Ryan Bayne
  • Publication number: 20240246105
    Abstract: A coating device includes at least one applicator configured to coat a glue onto two opposite sides of an electrode sheet; at least one roller assembly configured to guide the electrode sheet past the at least one applicator; and at least one support bar arranged under the at least one applicator.
    Type: Application
    Filed: January 18, 2024
    Publication date: July 25, 2024
    Applicant: Nordson Corporation
    Inventors: Peter QIU, Neil REN, Kevin JIANG, Andrew HU, Lock CHEN, Mikky SHAO, Charles YI
  • Publication number: 20240216346
    Abstract: The present invention includes substituted chromenones that are useful to inhibit the IRE1/XBP-1 pathway. In certain embodiments, the compounds of the invention inhibit IRE1's RNase activity. In other embodiments, the compounds of the invention are useful to treat or prevent a cancer that involve activation of the ER stress response. The invention also relates, in certain aspects, to the discovery that secretory IgM (sIgM) can orchestrate an immunosuppressive microenvironment by recruiting myeloid-derived suppressor cells (MDSCs) into different tumor models, such as but not limited to solid tumors (such as lung cancer) and tumors that have high levels of secreted IgM. In certain embodiments, sIgM produced by B cells or CLL cells can contribute to the accumulation of MDSCs in a tumor. In other embodiments, inhibition of the IRE1/XBP-1 pathway can ablate, minimize, or reduce MDSC levels in a tumor.
    Type: Application
    Filed: October 5, 2023
    Publication date: July 4, 2024
    Inventors: Chih-Chi Andrew Hu, Juan R. Del Valle
  • Patent number: 11945789
    Abstract: Disclosed are XBP-1/IRE-1 inhibitors having formula disclosed herein. Methods of making and using these inhibitors for the treatment of cancer, in particular B cell cancers, are also disclosed. Also disclosed is a genetic XBP-1-knockout cancer mouse model.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: April 2, 2024
    Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
    Inventors: Juan R. Del Valle, Chih-Chi Andrew Hu
  • Publication number: 20240005950
    Abstract: A phonograph record player including a speaker enclosure within the record player that is mechanically insulated from the phonograph components to reduce vibrations from the speakers to the phonograph components. One or more coupling mechanisms are used that absorb, reduce, and/or minimize vibrations generated by components coupled to a secondary housing, such as speakers, from being transmitted to a primary housing that includes a turntable.
    Type: Application
    Filed: September 8, 2022
    Publication date: January 4, 2024
    Inventors: Jordan Gregory Rapp, Byron Andrew Hu, Donald Louis Inmon II, Aaron Todd Fournier
  • Patent number: 11833137
    Abstract: The present invention includes substituted chromenones that are useful to inhibit the IRE1/XBP-1 pathway. In certain embodiments, the compounds of the invention inhibit IRE1's RNase activity. In other embodiments, the compounds of the invention are useful to treat or prevent a cancer that involve activation of the ER stress response. The invention also relates, in certain aspects, to the discovery that secretory IgM (sIgM) can orchestrate an immunosuppressive microenvironment by recruiting myeloid-derived suppressor cells (MDSCs) into different tumor models, such as but not limited to solid tumors (such as but not limited to lung cancer) and tumors that have high levels of secreted IgM. In certain embodiments, sIgM produced by B cells or CLL cells can contribute to the accumulation of MDSCs in a tumor. In other embodiments, inhibition of the IRE1/XBP-1 pathway can ablate, minimize, or reduce MDSC levels in a tumor.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: December 5, 2023
    Assignees: The Wistar Institute, University of South Florida
    Inventors: Chih-Chi Andrew Hu, Juan R. Del Valle
  • Publication number: 20200024247
    Abstract: Disclosed are XBP-1/IRE-1 inhibitors having formula disclosed herein. Methods of making and using these inhibitors for the treatment of cancer, in particular B cell cancers, are also disclosed. Also disclosed is a genetic XBP-1-knockout cancer mouse model.
    Type: Application
    Filed: March 18, 2019
    Publication date: January 23, 2020
    Inventors: Juan R. Del Valle, Chih-Chi Andrew Hu
  • Patent number: 10323013
    Abstract: Disclosed are XBP-1/IRE-1 inhibitors having formula disclosed herein. Methods of making and using these inhibitors for the treatment of cancer, in particular B cell cancers, are also disclosed. Also disclosed is a genetic XBP-1-knockout cancer mouse model. In still further aspects, the disclosed subject matter relates to methods for treating oncological and inflammatory disorders in a patient. For example, disclosed herein are methods whereby an effective amount of a compound or composition disclosed herein is administered to a patient having an oncological disorder, for example B-cell chronic lymphocytic leukemia (CLL), and who is in need of treatment thereof. XBP-1 deficiency causes leukemic cells to acquire phenotypes that are disadvantageous for their survival, such as compromised BCR signaling capability and increased surface expression of S1P1.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: June 18, 2019
    Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
    Inventors: Juan R. Del Valle, Chih-Chi Andrew Hu
  • Publication number: 20160083361
    Abstract: Disclosed are XBP-1/IRE-1 inhibitors having formula disclosed herein. Methods of making and using these inhibitors for the treatment of cancer, in particular B cell cancers, are also disclosed. Also disclosed is a genetic XBP-1-knockout cancer mouse model. In still further aspects, the disclosed subject matter relates to methods for treating oncological and inflammatory disorders in a patient. For example, disclosed herein are methods whereby an effective amount of a compound or composition disclosed herein is administered to a patient having an oncological disorder, for example B-cell chronic lymphocytic leukemia (CLL), and who is in need of treatment thereof. XBP-1 deficiency causes leukemic cells to acquire phenotypes that are disadvantageous for their survival, such as compromised BCR signaling capability and increased surface expression of S1 P1.
    Type: Application
    Filed: April 23, 2014
    Publication date: March 24, 2016
    Inventors: Juan R. Del Valle, Chih-Chi Andrew Hu
  • Publication number: 20070134594
    Abstract: A fluorescent dye, a structure of a fluorescent storage media and method using thereof, are disclosed. The fluorescent dye of the present invention comprises an organic violet fluorescent compound having a chemical structure (I) is suitable for using a short wavelength laser having a wavelength less than 500 nm as an excitation source. When a short wavelength laser is used for exciting the organic violet fluorescent compound (I), a fluorescence having an emission wavelength larger than 500 nm is induced, and a reading signal can be provided by detecting the intensity of the fluorescence radiation.
    Type: Application
    Filed: April 24, 2006
    Publication date: June 14, 2007
    Inventors: Ming-Chia Lee, Wen-Yih Liao, Huei-Wen Yang, Ching-Yu Hsieh, Chien-Liang Huang, Tzuan-Ren Jeng, Andrew Hu, Chien-Wen Chen, Chung-Chun Lee
  • Patent number: 4600258
    Abstract: A safety socket comprising a socket, a partition board, a hood and a cover is disclosed. A sliding partition board mounted between the socket and the hood is provided. One end of the partition board covers the socket and the other end extends to the outer part of the socket to form a handle. Two spots are provided in the main body of the partition board which correspond to the receptacles of the socket. On the underside of the partition board a column protrudes with a spring chamber retaining a spring. When the socket is not in use the spring loaded partition board automatically disaligns itself with the receptacles. To use the socket, simply pull back on the handle until the receptacles and the slots on the partition board are aligned.
    Type: Grant
    Filed: July 23, 1985
    Date of Patent: July 15, 1986
    Inventor: Andrew Hu